All Stories

  1. Long-term predictors for psychological outcome of pre-symptomatic testing for LONDs
  2. Risk perception in subjects at-risk for Familial Amyloidotic Polyneuropathy
  3. Life paths of patients with transthyretin-related familial amyloid polyneuropathy Val30Met: a descriptive study
  4. Paula Coutinho’s outstanding contribution to the definition of Machado-Joseph disease
  5. Massive sequencing of 70 genes reveals a myriad of missing genes or mechanisms to be uncovered in hereditary spastic paraplegias
  6. A Pentanucleotide ATTTC Repeat Insertion in the Non-coding Region of DAB1 , Mapping to SCA37 , Causes Spinocerebellar Ataxia
  7. Discredited legacy: Stigma and familial amyloid polyneuropathy in Northwestern Portugal
  8. Spinocerebellar ataxia type 10: common haplotype and disease progression rate in Peru and Brazil
  9. A Trans-acting Factor May Modify Age at Onset in Familial Amyloid Polyneuropathy ATTRV30M in Portugal
  10. Ubiquitin-related network underlain by (CAG)n loci modulate age at onset in Machado-Joseph disease
  11. Rare Neurodegenerative Diseases: Clinical and Genetic Update
  12. Familial amyloid polyneuropathy in Portugal: New genes modulating age-at-onset
  13. (CAG) n loci as genetic modifiers of age-at-onset in patients with Machado-Joseph disease from mainland China
  14. Large-Scale Functional RNAi Screen in C. elegans Identifies TGF-β and Notch Signaling Pathways as Modifiers of CACNA1A
  15. Illness representations
  16. Mid- and long-term anxiety levels associated with presymptomatic testing
  17. Depression as the Middle- and Long-Term Impact for Pre-Symptomatic Testing of Late-Onset Neurodegenerative Disorders
  18. Variants in RBP4 and AR genes modulate age at onset in familial amyloid polyneuropathy (FAP ATTRV30M)
  19. How communication of genetic information within the family is addressed in genetic counselling: a systematic review of research evidence
  20. Erratum to: Genomic analysis in the clinic: benefits and challenges for health care professionals and patients in Brazil
  21. Genetics and ethics in Latin America
  22. Genomic analysis in the clinic: benefits and challenges for health care professionals and patients in Brazil
  23. Subjects At-Risk for Genetic Diseases in Portugal
  24. Genetic Counseling in Portugal: Education, Practice and a Developing Profession
  25. Mutations in PNKP Cause Recessive Ataxia with Oculomotor Apraxia Type 4
  26. Quality issues concerning genetic counselling for presymptomatic testing: a European Delphi study
  27. Haplotype analysis of the 4p16.3 region in Portuguese families with Huntington's disease
  28. Chromosome substitution strain assessment of a Huntington’s disease modifier locus
  29. Genetics Health Professionals’ Views on Quality of Genetic Counseling Service Provision for Presymptomatic Testing in Late-Onset Neurological Diseases in Portugal: Core Components, Specific Challenges and the Need for Assessment Tools
  30. Points to consider for prioritizing clinical genetic testing services: a European consensus process oriented at accountability for reasonableness
  31. Modifiers of (CAG)n instability in Machado–Joseph disease (MJD/SCA3) transmissions: an association study with DNA replication, repair and recombination genes
  32. Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy
  33. Machado–Joseph disease in a Nigerian family: mutational origin and review of the literature
  34. Familial hemiplegic migraine due to L263V SCN1A mutation: Discordance for epilepsy between two kindreds from Douro Valley
  35. Identification of Genetic Risk Factors for Maxillary Lateral Incisor Agenesis
  36. Insufficient Referral for Genetic Counseling in the Management of Hereditary Haemochromatosis in Portugal: A Study of Perceptions of Health Professionals Requesting HFE Genotyping
  37. [NO TITLE AVAILABLE]
  38. Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policyEuropean Society of Human Genetics and European Society of Human Reproduction and Embryology
  39. The Prevalence of Familial Hemiplegic Migraine With Cerebellar Ataxia and Spinocerebellar Ataxia Type 6 in Portugal
  40. Huntington disease and Huntington disease-like in a case series from Brazil
  41. Overcoming artefact: anticipation in 284 Portuguese kindreds with familial amyloid polyneuropathy (FAP) ATTRV30M
  42. Interaction between γ-Aminobutyric Acid A Receptor Genes: New Evidence in Migraine Susceptibility
  43. Hereditary Ataxia and Spastic Paraplegia in Portugal
  44. Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington’s disease motor onset
  45. Autosomal Dominant Spastic Paraplegias
  46. Recommendations for the predictive genetic test in Huntington's disease
  47. Cerebellar Ataxia, Hemiplegic Migraine, and Related Phenotypes Due to a CACNA1A Missense Mutation
  48. Non-syndromic Sensorineural Prelingual Deafness: The Importance of Genetic Counseling in Demystifying Parents’ Beliefs About the Cause of Their Children’s Deafness
  49. What Counts as Effective Genetic Counselling for Presymptomatic Testing in Late-Onset Disorders? A Study of the Consultand’s Perspective
  50. Assessing Risk Factors for Migraine: Differences in Gender Transmission
  51. The perspective from EASAC and FEAM on direct-to-consumer genetic testing for health-related purposes
  52. Spinocerebellar ataxias: An example of the challenges associated with genetic databases for dynamic mutations
  53. TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington’s disease
  54. Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset
  55. The Challenges of Incorporating Genetic Testing in the Unified National Health System in Brazil
  56. Developing a policy for paediatric biobanks: principles for good practice
  57. Mutational Origin of Machado-Joseph Disease in the Australian Aboriginal Communities of Groote Eylandt and Yirrkala
  58. ‘Costa da Morte’ ataxia is spinocerebellar ataxia 36: clinical and genetic characterization
  59. Sequence Analysis of 5′ Regulatory Regions of the Machado–Joseph Disease Gene (ATXN3)
  60. Common SNP-Based Haplotype Analysis of the 4p16.3 Huntington Disease Gene Region
  61. The wide variation of definitions of genetic testing in international recommendations, guidelines and reports
  62. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
  63. Definitions of genetic testing in European legal documents
  64. Alu elements mediate large SPG11 gene rearrangements: further spatacsin mutations
  65. Quality Assessment of Genetic Counseling Process in the Context of Presymptomatic Testing for Late-Onset Disorders: A Thematic Analysis of Three Review Articles
  66. Epidemiology and population genetics of degenerative ataxias
  67. Intergenerational instability in Huntington disease: Extreme repeat changes among 134 transmissions
  68. Ataxia Rating Scales—Psychometric Profiles, Natural History and Their Application in Clinical Trials
  69. Investigating ANKH and ENPP1 in Slovakian families with chondrocalcinosis
  70. Y-STR haplotypes in three ethnic linguistic groups of Angola population
  71. Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities
  72. FXTAS is rare among Portuguese patients with movement disorders: FMR1 premutations may be associated with a wider spectrum of phenotypes
  73. Rett syndrome with and without detected MECP2 mutations: An attempt to redefine phenotypes
  74. Does DNA methylation in the promoter region of the ATXN3 gene modify age at onset in MJD (SCA3) patients?
  75. A role for endothelin receptor type A in migraine without aura susceptibility? A study in Portuguese patients
  76. Genetic study of 15 STRs loci of Identifiler system in Angola population
  77. A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura
  78. Large normal and reduced penetrance alleles in Huntington disease: instability in families and frequency at the laboratory, at the clinic and in the population
  79. Death Anxiety and Symbolic Immortality in Relatives at Risk for Familial Amyloid Polyneuropathy Type I (FAP I, ATTR V30M)
  80. BDNF and CGRP interaction: Implications in migraine susceptibility
  81. Genetic education and the challenge of genomic medicine: development of core competences to support preparation of health professionals in Europe
  82. Evidence of Syntaxin 1A Involvement in Migraine Susceptibility
  83. Trastornos nutricionales y gastrointestinales en el síndrome de Rett: importancia de la intervención temprana
  84. Scope of definitions of genetic testing: evidence from a EuroGentest survey
  85. Consensus and controversies in best practices for molecular genetic testing of spinocerebellar ataxias
  86. EMQN Best Practice Guidelines for molecular genetic testing of SCAs
  87. Massively parallel sequencing of ataxia genes after array-based enrichment
  88. Ataxia and Progressive Encephalopathy in a 4-Year-Old Girl
  89. Genetic Screening in Europe
  90. Regulating Genetic Testing: The Relevance of Appropriate Definitions
  91. Role of the Disease in the Psychological Impact of Pre-Symptomatic Testing for SCA2 and FAP ATTRV30M: Experience with the Disease, Kinship and Gender of the Transmitting Parent
  92. Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients
  93. Erratum: Direct to consumer genetic tests
  94. Common origin of pure and interrupted repeat expansions in spinocerebellar ataxia type 2 (SCA2)
  95. Autosomal dominant cerebellar ataxia: frequency analysis and clinical characterization of 45 families from Portugal
  96. Direct to consumer genetic tests
  97. Genetic testing in asymptomatic minorsBackground considerations towards ESHG Recommendations
  98. Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics
  99. Genetic horoscopes: is it all in the genes? Points for regulatory control of direct-to-consumer genetic testing
  100. Familial Clustering of Migraine: Further Evidence From a Portuguese Study
  101. First Mutation in the Voltage-Gated Nav1.1 Subunit Gene SCN1A with Co-Occurring Familial Hemiplegic Migraine and Epilepsy
  102. Ancestral Origin of the ATTCT Repeat Expansion in Spinocerebellar Ataxia Type 10 (SCA10)
  103. NovelSPG3AandSPG4mutations in dominant spastic paraplegia families
  104. Response to Tumas et al.
  105. Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment
  106. Motor and cognitive deficits in the heterozygous leaner mouse, a Cav2.1 voltage-gated Ca2+ channel mutant
  107. Erratum: Patenting and licensing in genetic testing: Recommendations of the European Society of Human Genetics
  108. Movement disorders in Rett syndrome: An analysis of 60 patients with detected MECP2 mutation and correlation with mutation type
  109. Regulations and practices of genetic counselling in 38 European countries: the perspective of national representatives
  110. Patenting and licensing in genetic testing
  111. Patenting and licensing in genetic testing: ethical, legal and social issues
  112. Atypical stereotypies and vocal tics in Rett syndrome: An illustrative case
  113. Huntington disease-like 2: the first patient with apparent European ancestry
  114. Experience and outcome of 3 years of a European EQA scheme for genetic testing of the spinocerebellar ataxias
  115. What is ideal genetic counselling? A survey of current international guidelines
  116. Cis-acting factors promoting the CAG intergenerational instability in Machado–Joseph disease
  117. EuroGentest: DNA-Based Testing for Heritable Disorders in Europe
  118. Two novel functional mutations in the Na+,K+-ATPase α2-subunit ATP1A2 gene in patients with familial hemiplegic migraine and associated neurological phenotypes
  119. NEDD8: A new ataxin-3 interactor
  120. Recurrent ATP1A2 mutations in Portuguese families with familial hemiplegic migraine
  121. Asian Origin for the Worldwide-Spread Mutational Event in Machado-Joseph Disease
  122. Machado-Joseph Disease Enhances Genetic Fitness: A Comparison Between Affected and Unaffected Women and Between MJD and the General Population
  123. Stereotypies in Rett syndrome: Analysis of 83 patients with and without detected MECP2 mutations
  124. Psychological Follow-up of Presymptomatic Genetic Testing for Spinocerebellar Ataxia Type 2 (SCA2) in Cuba
  125. Functional genomics and biochemical characterization of the C. elegans orthologue of the Machado-Joseph disease protein ataxin-3
  126. Abnormal movements in Rett syndrome are present before the regression period: A case study
  127. Report of an International Survey of Molecular Genetic Testing Laboratories
  128. Depressive Symptoms in Machado-Joseph Disease (SCA3) Patients and Their Relatives
  129. The interface between medically assisted reproduction and genetics: technical, social, ethical and legal issues*
  130. The Perceived Advantages and Disadvantages of Presymptomatic Testing for Machado-Joseph Disease: Development of a New Self-Response Inventory
  131. Exclusion of mutations in the PRNP, JPH3, TBP, ATN1, CREBBP, POU3F2 and FTL genes as a cause of disease in Portuguese patients with a Huntington-like phenotype
  132. Spinocerebellar ataxias in 114 Brazilian families: clinical and molecular findings
  133. Reduced penetrance of intermediate size alleles in spinocerebellar ataxia type 10
  134. A multistep mutation mechanism drives the evolution of the CAG repeat at MJD/SCA3 locus
  135. The need for interaction between assisted reproduction technology and genetics: recommendations of the European Societies of Human Genetics and Human Reproduction and Embryology
  136. The interface between assisted reproductive technologies and genetics: technical, social, ethical and legal issues
  137. The need for interaction between assisted reproduction technology and genetics
  138. Psychological aspects of pre-symptomatic testing for Machado-Joseph disease and familial amyloid polyneuropathy type I
  139. The CAG repeat at the Huntington disease gene in the Portuguese population: insights into its dynamics and to the origin of the mutation
  140. In Memoriam
  141. Haplotype diversity and somatic instability in normal and expanded SCA8 alleles
  142. Nonsense mutation in TITF1 in a Portuguese family with benign hereditary chorea
  143. A novel H101Q mutation causes PKCγ loss in spinocerebellar ataxia type 14
  144. Neuroferritinopathy: Missense mutation in FTL causing early-onset bilateral pallidal involvement
  145. Population Genetics of Wild-Type CAG Repeats in the Machado-Joseph Disease Gene in Portugal
  146. Genomic structure, promoter activity, and developmental expression of the mouse homologue of the Machado–Joseph disease (MJD) gene☆
  147. Frataxin overexpressing mice
  148. Genotypes at the APOE and SCA2 loci do not predict the course of multiple sclerosis in patients of Portuguese origin
  149. End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors
  150. Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2
  151. A novel R1347Q mutation in the predicted voltage sensor segment of the P/Q-type calcium-channel α1A-subunit in a family with progressive cerebellar ataxia and hemiplegic migraine
  152. Molecular diagnosis of Huntington disease in Portugal: implications for genetic counselling and clinical practice
  153. A whole genome screen for association with multiple sclerosis in Portuguese patients
  154. Portuguese families with dentatorubropallidoluysian atrophy (DRPLA) share a common haplotype of Asian origin
  155. Genetic interaction ofCTLA-4 with HLA-DR15 in multiple sclerosis patients
  156. Phenotypes of Spinocerebellar Ataxia Type 6 and Familial Hemiplegic Migraine Caused by a Unique CACNA1A Missense Mutation in Patients From a Large Family
  157. Familial ATTR amyloidosis: microalbuminuria as a predictor of symptomatic disease and clinical nephropathy
  158. Searching for modulating effects of SCA2, SCA6 and DRPLA CAG tracts on the Machado-Joseph disease (SCA3) phenotype
  159. Use of fluoxetine for treatment of Machado-Joseph disease: an open-label study
  160. Inherited and acquired risk factors and their combined effects in pediatric stroke
  161. Iron metabolism in mice with partial frataxin deficiency
  162. Frataxin knockin mouse
  163. A survey of spinocerebellar ataxia in South Brazil - 66 new cases with Machado-Joseph disease, SCA7, SCA8, or unidentified disease-causing mutations
  164. Machado-Joseph disease in South Brazil: clinical and molecular characterization of kindreds
  165. Homozygosity Mapping of Portuguese and Japanese Forms of Ataxia-Oculomotor Apraxia to 9p13, and Evidence for Genetic Heterogeneity
  166. High Germinal Instability of the (CTG)n at the SCA8 Locus of Both Expanded and Normal Alleles
  167. Prenatal diagnosis of Machado–Joseph disease by direct mutation analysis
  168. Analysis of SCA1, DRPLA, MJD, SCA2, and SCA6 CAG repeats in 48 portuguese ataxia families
  169. Linkage disequilibrium analysis in Machado-Joseph disease patients of different ethnic origins
  170. Somatic mosaicism in the central nervous system in spinocerebellar ataxia type 1 and machado-joseph disease
  171. Frequency of spinocerebellar ataxia type 1, dentatorubropallidoluysian atrophy, and Machado-Joseph disease mutations in a large group of spinocerebellar ataxia patients
  172. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Póvoa do Varzim and Vila do Conde (north of Portugal)
  173. Gender equality in Machado–Joseph disease
  174. Genetic Linkage Studies of Machado-Joseph Disease with Chromosome 14q STRPs in 16 Portuguese-Azorean Kindreds
  175. Machado-Joseph Disease Is Genetically Different from Holguin Dominant Ataxia (SCA2)
  176. Onset in the seventh decade and lack of symptoms in heterozygotes for the TTRMet30 mutation in hereditary amyloid neuropathy—type I (Portuguese, Andrade)
  177. Machado-Joseph Disease in a Sicilian-American Family
  178. Infection and Prematurity as the Cause of Linear Skin Atrophy, Alopecia, Anonychia, and Tongue Lesions?
  179. Linear skin atrophy, scarring alopecia, anonychia, and tongue lesion: A “new” syndrome?
  180. Machado-Joseph Disease in an American-Italian Family